person
as of 2026-07-01Jari Tiihonen, MD, PhD
ORCID 0000-0002-0400-6798
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 10
2 publications · 1 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Niuvanniemi Hospital
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
10
Publications
2 (1 high-value)
Trial investigator
yes
Publishes on
1 drugs
Trials led
1
Polypharmacy in Clozapine-resistant Schizophrenia
NCT00918021Phase 4Completed
Publications & congress
2
Systematic review of stranger homicides by psychotic individuals.
Schizophrenia bulletin · 2026 · high-value
Brexpiprazole in the Management of Schizophrenia: A Consensus Report of Best Practices From Acute to Maintenance Treatment.
Neuropsychiatric disease and treatment · 2025
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
PRINCIPAL_INVESTIGATOR